Latest Updates

The drug 'Dinutuximab beta Apeiron' improves the survival and chances for cure in the severe paediatric cancer neuroblastoma

Panelists divided on the impact of the push for generics, many laud the intent but skeptical of consequences

In FY17, revenues were at Rs 140.8 billion and EBITDA at Rs 25.5 billion

The company will export the first shipment of lifesaving drugs to Kenya shortly

The facility will provide biopharmaceutical manufacturers with a shared, exploratory environment where they can collaborate with…

This approval is the outcome of the inspection of Goa Plant I, which was conducted in December 2016

Study methodology involved a nine-month evaluation by an external panel of independent jury

The association suggests that the government should abolish tax on all medicines and subsidise the price of medicines as is done…

The US Court of Appeals for the Federal Circuit has affirmed judgement holding that Zydus Cadila's proposed generic version of…

The company has priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP Rs 5,000, Rs 10,000 and Rs 20,000…